The Cooper Companies, Inc. (LON:0I3I)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 11.09B +6.4% |
| Revenue (ttm) | 3.12B +6.1% |
| Net Income | 173.64M -43.1% |
| EPS | 0.87 -42.8% |
| Shares Out | n/a |
| PE Ratio | 63.87 |
| Forward PE | 16.22 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35 |
| Open | 78.00 |
| Previous Close | 76.85 |
| Day's Range | 74.79 - 78.00 |
| 52-Week Range | 57.64 - 89.11 |
| Beta | 0.82 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 9, 2026 |
About The Cooper Companies
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor... [Read more]
Financial Performance
In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.
Financial numbers in USD Financial StatementsNews
CooperCompanies Announces Release Date for Third Quarter 2026
SAN RAMON, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report third quarter 2026 financial results on Wedn...
Cooper Companies initiated with a Neutral at UBS
UBS initiated coverage of Cooper Companies (COO) with a Neutral rating and $75 price target The eyecare sector is healthier than expected, with resilient U.S. consumer demand, strong performance in…
Cooper Companies initiated with a Neutral at UBS
UBS analyst Patrick Wood initiated coverage of Cooper Companies (COO) with a Neutral rating and $75 price target
Cooper Companies price target raised to $76 from $69 at Citi
Citi analyst Joanne Wuensch raised the firm’s price target on Cooper Companies (COO) to $76 from $69 and keeps a Neutral rating on the shares.
CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure
SAN RAMON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, released today its 2025 Corporate Sustainability Report. The report showcas...
Cooper Companies rises 7.5%
Cooper Companies (COO) is up 7.5%, or $4.68 to $66.70.
Cooper Cos. Is One of Today's Top S&P 500 Stocks.
The medical device maker gave an update on its troubled CooperSurgical business segment that was music to Wall Street's ears.
Cooper Companies rises 6.9%
Cooper Companies (COO) is up 6.9%, or $4.25 to $66.27.
Cooper Companies price target lowered to $71 from $80 at JPMorgan
JPMorgan analyst Robbie Marcus lowered the firm’s price target on Cooper Companies (COO) to $71 from $80 and keeps a Neutral rating on the shares. The company reported a better…
Cooper Companies price target lowered to $86 from $101 at Needham
Needham lowered the firm’s price target on Cooper Companies (COO) to $86 from $101 and keeps a Buy rating on the shares. The company’s Q2 revenue and EPS beat consensus…
Cooper Companies price target lowered to $85 from $95 at Stifel
Stifel lowered the firm’s price target on Cooper Companies (COO) to $85 from $95 and keeps a Buy rating on the shares. While fiscal Q2 results and 2026 guidance “was…
Cooper Companies price target lowered to $85 from $98 at Baird
Baird lowered the firm’s price target on Cooper Companies (COO) to $85 from $98 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results.
Cooper Companies price target lowered to $66 from $82 at Wells Fargo
Wells Fargo lowered the firm’s price target on Cooper Companies (COO) to $66 from $82 and keeps an Equal Weight rating on the shares. The company is moving ahead with…
The Cooper Companies Earnings Call Transcript: Q2 2026
Record Q2 revenue and EPS growth driven by strong performance in both CooperVision and CooperSurgical, despite Asia-Pac softness and a significant litigation charge. Strategic review of CooperSurgical is advancing, with robust interest and potential for increased share buybacks.
The Cooper Companies Earnings release: Q2 2026
The Cooper Companies released its Q2 2026 earnings on June 4, 2026, summarizing the period's financial results.
The Cooper Companies Slides: Q2 2026
The Cooper Companies has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on June 4, 2026.
The Cooper Companies Quarterly report: Q2 2026
The Cooper Companies has published its Q2 2026 quarterly earnings report on June 4, 2026.
CooperCompanies Announces Second Quarter 2026 Results
SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April...
Cooper Companies price target lowered to $85 from $100 at Mizuho
Mizuho lowered the firm’s price target on Cooper Companies (COO) to $85 from $100 and keeps an Outperform rating on the shares ahead of fiscal Q2 report. The firm cites…
CooperCompanies Appoints Paul Keel to its Board of Directors
SAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an in...
CooperCompanies Announces Release Date for Second Quarter 2026
SAN RAMON, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report second quarter 2026 financial results on Th...
CooperVision Launches MADE BETTER™ Promise Beginning with MyDay® Contact Lenses*¹
New sustainability platform reflects company's commitment to responsible sourcing, moreefficient manufacturing, and offsetting a portion of plastic footprint *†1 ROCHESTER, N.Y., April 9, 2026 /PRNews...
The Cooper Companies Earnings Call Transcript: Q1 2026
Q1 2026 saw strong revenue and earnings growth, driven by product launches, operational efficiencies, and robust cash flow. Guidance for earnings and free cash flow was raised, with continued momentum expected in the Americas and EMEA, while Asia Pac is set to recover in the second half.
The Cooper Companies Quarterly report: Q1 2026
The Cooper Companies has published its Q1 2026 quarterly earnings report on March 5, 2026.
The Cooper Companies Earnings release: Q1 2026
The Cooper Companies released its Q1 2026 earnings on March 5, 2026, summarizing the period's financial results.